Royalty Pharma PLCNASDAQ:RPRX
- LAST PRICE26.3700
- TODAY'S CHANGE (%)-0.3000 (-1.1249%)
- Bid / Lots26.0000/ 2
- Ask / Lots27.9000/ 1
- Open / Previous Close26.7700 / 26.6700
- Day Range
- 52 Week Range
- Volume5,222,619
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | RPRX |
|---|---|---|
| 09:32 ET | 14071 | 26.5901 |
| 09:34 ET | 2153 | 26.73 |
| 09:36 ET | 1899 | 26.71 |
| 09:38 ET | 9887 | 26.805 |
| 09:39 ET | 2571 | 26.79 |
| 09:41 ET | 1187 | 26.77 |
| 09:43 ET | 1402 | 26.72 |
| 09:45 ET | 1384 | 26.71 |
| 09:48 ET | 900 | 26.7 |
| 09:50 ET | 3983 | 26.66 |
| 09:52 ET | 3287 | 26.69 |
| 09:54 ET | 1814 | 26.71 |
| 09:56 ET | 5379 | 26.755 |
| 09:57 ET | 700 | 26.76 |
| 09:59 ET | 2071 | 26.74 |
| 10:01 ET | 2200 | 26.76 |
| 10:03 ET | 5315 | 26.81 |
| 10:06 ET | 6487 | 26.84 |
| 10:08 ET | 2900 | 26.855 |
| 10:10 ET | 6621 | 26.84 |
| 10:12 ET | 1457 | 26.835 |
| 10:14 ET | 7269 | 26.82 |
| 10:15 ET | 10064 | 26.77 |
| 10:17 ET | 5406 | 26.7 |
| 10:19 ET | 2544 | 26.695 |
| 10:21 ET | 2475 | 26.685 |
| 10:24 ET | 9901 | 26.685 |
| 10:26 ET | 39369 | 26.69 |
| 10:28 ET | 25438 | 26.685 |
| 10:30 ET | 4833 | 26.685 |
| 10:32 ET | 4785 | 26.695 |
| 10:33 ET | 7107 | 26.68 |
| 10:35 ET | 13320 | 26.675 |
| 10:37 ET | 2337 | 26.68 |
| 10:39 ET | 3597 | 26.685 |
| 10:42 ET | 10170 | 26.68 |
| 10:44 ET | 1621 | 26.68 |
| 10:46 ET | 3758 | 26.6602 |
| 10:48 ET | 4913 | 26.6952 |
| 10:50 ET | 5478 | 26.67 |
| 10:51 ET | 11640 | 26.705 |
| 10:53 ET | 5043 | 26.675 |
| 10:55 ET | 4157 | 26.685 |
| 10:57 ET | 2700 | 26.655 |
| 11:00 ET | 2353 | 26.655 |
| 11:02 ET | 17396 | 26.645 |
| 11:04 ET | 6825 | 26.61 |
| 11:06 ET | 7398 | 26.57 |
| 11:08 ET | 6296 | 26.57 |
| 11:09 ET | 5010 | 26.53 |
| 11:11 ET | 2589 | 26.53 |
| 11:13 ET | 6534 | 26.54 |
| 11:15 ET | 6832 | 26.52 |
| 11:18 ET | 5282 | 26.5 |
| 11:20 ET | 4972 | 26.505 |
| 11:22 ET | 5510 | 26.515 |
| 11:24 ET | 2661 | 26.515 |
| 11:26 ET | 900 | 26.51 |
| 11:27 ET | 1864 | 26.515 |
| 11:29 ET | 8800 | 26.49 |
| 11:31 ET | 5266 | 26.505 |
| 11:33 ET | 4942 | 26.505 |
| 11:36 ET | 6586 | 26.52 |
| 11:38 ET | 4551 | 26.5 |
| 11:40 ET | 4557 | 26.5 |
| 11:42 ET | 4077 | 26.51 |
| 11:44 ET | 1093 | 26.515 |
| 11:45 ET | 8416 | 26.53 |
| 11:47 ET | 3276 | 26.515 |
| 11:49 ET | 2041 | 26.5 |
| 11:51 ET | 4588 | 26.48 |
| 11:54 ET | 7182 | 26.475 |
| 11:56 ET | 3186 | 26.49 |
| 11:58 ET | 5523 | 26.505 |
| 12:00 ET | 4627 | 26.505 |
| 12:02 ET | 4864 | 26.49 |
| 12:03 ET | 2599 | 26.4881 |
| 12:05 ET | 700 | 26.48 |
| 12:07 ET | 7818 | 26.495 |
| 12:09 ET | 7901 | 26.465 |
| 12:12 ET | 9396 | 26.44 |
| 12:14 ET | 4719 | 26.42 |
| 12:16 ET | 8314 | 26.39 |
| 12:18 ET | 12242 | 26.38 |
| 12:20 ET | 8395 | 26.38 |
| 12:21 ET | 11415 | 26.375 |
| 12:23 ET | 4381 | 26.39 |
| 12:25 ET | 6116 | 26.38 |
| 12:27 ET | 6704 | 26.4 |
| 12:30 ET | 1990 | 26.38 |
| 12:32 ET | 13683 | 26.38 |
| 12:34 ET | 9249 | 26.36 |
| 12:36 ET | 6713 | 26.36 |
| 12:38 ET | 5493 | 26.375 |
| 12:39 ET | 9504 | 26.375 |
| 12:41 ET | 4659 | 26.385 |
| 12:43 ET | 5051 | 26.375 |
| 12:45 ET | 5500 | 26.36 |
| 12:48 ET | 5378 | 26.371 |
| 12:50 ET | 2907 | 26.37 |
| 12:52 ET | 4269 | 26.36 |
| 12:54 ET | 8079 | 26.34 |
| 12:56 ET | 4485 | 26.32 |
| 12:57 ET | 5779 | 26.32 |
| 12:59 ET | 14652 | 26.32 |
| 01:01 ET | 6558 | 26.32 |
| 01:03 ET | 9846 | 26.3 |
| 01:06 ET | 9020 | 26.33 |
| 01:08 ET | 4153 | 26.33 |
| 01:10 ET | 5448 | 26.3675 |
| 01:12 ET | 5824 | 26.37 |
| 01:14 ET | 3815 | 26.355 |
| 01:15 ET | 8943 | 26.33 |
| 01:17 ET | 5281 | 26.3175 |
| 01:19 ET | 3397 | 26.32 |
| 01:21 ET | 8425 | 26.315 |
| 01:24 ET | 700 | 26.315 |
| 01:26 ET | 3263 | 26.345 |
| 01:28 ET | 2721 | 26.355 |
| 01:30 ET | 4431 | 26.355 |
| 01:32 ET | 7537 | 26.36 |
| 01:33 ET | 6947 | 26.37 |
| 01:35 ET | 12639 | 26.34 |
| 01:37 ET | 7382 | 26.31 |
| 01:39 ET | 673 | 26.31 |
| 01:42 ET | 1615 | 26.315 |
| 01:44 ET | 11605 | 26.325 |
| 01:46 ET | 1905 | 26.34 |
| 01:48 ET | 1001 | 26.345 |
| 01:50 ET | 2691 | 26.345 |
| 01:51 ET | 4049 | 26.35 |
| 01:53 ET | 4320 | 26.345 |
| 01:55 ET | 4987 | 26.33 |
| 01:57 ET | 860 | 26.33 |
| 02:00 ET | 4552 | 26.325 |
| 02:02 ET | 4665 | 26.295 |
| 02:04 ET | 2092 | 26.295 |
| 02:06 ET | 5551 | 26.3 |
| 02:08 ET | 5516 | 26.3142 |
| 02:09 ET | 2222 | 26.325 |
| 02:11 ET | 6379 | 26.3 |
| 02:13 ET | 4241 | 26.295 |
| 02:15 ET | 400 | 26.29 |
| 02:18 ET | 10938 | 26.305 |
| 02:20 ET | 4867 | 26.305 |
| 02:22 ET | 6016 | 26.315 |
| 02:24 ET | 9969 | 26.335 |
| 02:26 ET | 2122 | 26.325 |
| 02:27 ET | 7682 | 26.33 |
| 02:29 ET | 5244 | 26.345 |
| 02:31 ET | 5640 | 26.36 |
| 02:33 ET | 18154 | 26.35 |
| 02:36 ET | 6232 | 26.325 |
| 02:38 ET | 1456 | 26.32 |
| 02:40 ET | 1933 | 26.32 |
| 02:42 ET | 4394 | 26.335 |
| 02:44 ET | 12782 | 26.345 |
| 02:45 ET | 13748 | 26.33 |
| 02:47 ET | 3828 | 26.32 |
| 02:49 ET | 1031 | 26.32 |
| 02:51 ET | 3250 | 26.315 |
| 02:54 ET | 10046 | 26.32 |
| 02:56 ET | 1729 | 26.31 |
| 02:58 ET | 3785 | 26.315 |
| 03:00 ET | 2943 | 26.31 |
| 03:02 ET | 11059 | 26.3 |
| 03:03 ET | 3434 | 26.3 |
| 03:05 ET | 5633 | 26.29 |
| 03:07 ET | 12012 | 26.29 |
| 03:09 ET | 3821 | 26.27 |
| 03:12 ET | 5494 | 26.27 |
| 03:14 ET | 4819 | 26.265 |
| 03:16 ET | 6672 | 26.285 |
| 03:18 ET | 7486 | 26.26 |
| 03:20 ET | 10575 | 26.265 |
| 03:21 ET | 11109 | 26.275 |
| 03:23 ET | 4278 | 26.275 |
| 03:25 ET | 9377 | 26.264 |
| 03:27 ET | 16233 | 26.29 |
| 03:30 ET | 11599 | 26.285 |
| 03:32 ET | 10287 | 26.26 |
| 03:34 ET | 11091 | 26.2483 |
| 03:36 ET | 12508 | 26.245 |
| 03:38 ET | 1595 | 26.245 |
| 03:39 ET | 8732 | 26.255 |
| 03:41 ET | 26564 | 26.275 |
| 03:43 ET | 15267 | 26.255 |
| 03:45 ET | 11698 | 26.15 |
| 03:48 ET | 58034 | 26.21 |
| 03:50 ET | 11949 | 26.215 |
| 03:52 ET | 94685 | 26.35 |
| 03:54 ET | 56693 | 26.395 |
| 03:56 ET | 75770 | 26.345 |
| 03:57 ET | 99184 | 26.4 |
| 03:59 ET | 2815781 | 26.37 |
Jun 4, 2024
Royalty Pharma to Present at the Goldman Sachs 45th Annual Global Healthcare Conference, from 4:15PM ET on Tuesday Jun 04, 2024 by Dow Jones
4:15PM ET on Tuesday Jun 04, 2024 by Dow Jones
Jun 3, 2024
Press Release: Royalty Pharma Announces Pricing of $1.5 Billion of Senior Unsecured Notes, from 5:15PM ET on Monday Jun 03, 2024 by Dow Jones
5:15PM ET on Monday Jun 03, 2024 by Dow JonesRoyalty Pharma Announces Pricing of $1.5 Billion of Senior Unsecured Notes, from 5:15PM ET on Monday Jun 03, 2024 by Dow Jones
5:15PM ET on Monday Jun 03, 2024 by Dow JonesDJ Royalty Pharma Cut to Neutral From Buy by UBS, from 12:00PM ET on Monday Jun 03, 2024 by Dow Jones
12:00PM ET on Monday Jun 03, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Royalty Pharma PLC | 15.8B | 14.8x | +1.83% |
Amneal Pharmaceuticals Inc | 2.0B | -11.3x | --- |
Catalent Inc | 10.2B | -8.7x | --- |
Jazz Pharmaceuticals PLC | 6.7B | 22.0x | -3.53% |
Mallinckrodt PLC | 1.6M | 0.0x | --- |
Prestige Consumer Healthcare Inc | 3.4B | 16.5x | --- |
Company Information
Royalty Pharma plc is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The Company collaborates with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio consists of royalties on over 35 commercial products, including Vertex’s Trikafta, GSK’s Trelegy, Roche’s Evrysdi, Johnson & Johnson’s Tremfya, Biogen’s Tysabri and Spinraza, AbbVie and Johnson & Johnson’s Imbruvica, Astellas and Pfizer’s Xtandi, Novartis’ Promacta, Pfizer’s Nurtec ODT and Gilead’s Trodelvy, and 14 development-stage product candidates. Its development-stage product candidates include Aficamten, Ampreloxetine, BCX10013, MK-8189, Ecopipam, Olpasiran, Pelabresib, KarXT, Pelacarsen, Seltorexant, Trontinemab, TEV-'749, Tulmimetostat and Vanzacaftor. Its subsidiaries include Royalty Pharma Holdings Ltd., Royalty Pharma Investments and others.
Contact Information
- Headquarters
- 110 East 59th StreetNEW YORK, NY, United States 10022
- Phone
- 212-883-0200
- Fax
- ---
Executives
- Chairman of the Board, Chief Executive Officer
- Pablo Legorreta
- Vice Chairman, Executive Vice President
- Christopher Hite
- Chief Financial Officer, Executive Vice President
- Terrance Coyne
- Executive Vice President - Investments and Chief Legal Officer
- George Lloyd
- Executive Vice President - Research and Investments
- Marshall Urist
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $15.8B |
|---|---|
Revenue (TTM) | $2.2B |
Shares Outstanding | 597.4M |
Dividend Yield | 3.19% |
Annual Dividend Rate | 0.8400 USD |
Ex-Dividend Date | 05-16-24 |
Pay Date | 06-14-24 |
Beta | 0.46 |
EPS | $1.78 |
Book Value | $14.61 |
P/E Ratio | 14.8x |
Price/Sales (TTM) | 7.0 |
Price/Cash Flow (TTM) | 13.2x |
Operating Margin | 41.96% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
